Search Results - Ronan Swords
- Showing 1 - 17 results of 17
-
1
-
2
-
3
-
4
Autophagy inhibition enhances vorinostat‐induced apoptosis <i>via</i> ubiquitinated protein accumulation by Jennifer S. Carew, Ernest Medina, Juan Esquivel, Devalingam Mahalingam, Ronan Swords, Kevin R. Kelly, Hui Zhang, Peng Huang, Alain C. Mita, Monica Mita, Francis J. Giles, Steffan T. Nawrocki
Published 2009Artigo -
5
Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia by Ronan Swords, Kevin R. Kelly, Peter G. Smith, James Garnsey, Devalingam Mahalingam, Ernest Medina, Kelli Oberheu, Swaminathan P. Iyer, Michael O’Dwyer, Steffan T. Nawrocki, Francis J. Giles, Jennifer S. Carew
Published 2010Artigo -
6
Pevonedistat (<scp>MLN</scp>4924), a First‐in‐Class <scp>NEDD</scp>8‐activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1... by Ronan Swords, Harry P. Erba, Daniel J. DeAngelo, Dale L. Bixby, Jessica K. Altman, Michael B. Maris, Zhaowei Hua, Stephen J. Blakemore, Hélène M. Faessel, Farhad Sedarati, Bruce J. Dezube, Francis J. Giles, Bruno C. Medeiros
Published 2015Artigo -
7
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML by Ronan Swords, Steven Coutré, Michael B. Maris, Joshua F. Zeidner, James M. Foran, José C. Cruz, Harry P. Erba, Jesús G. Berdeja, Wayne Tam, Saran Vardhanabhuti, Iwona Pawlikowska-Dobler, Hélène M. Faessel, Ajeeta B. Dash, Farhad Sedarati, Bruce J. Dezube, Douglas V. Faller, Michael R. Savona
Published 2018Artigo -
8
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia by Curtis A. Lachowiez, Nicola Long, Jennifer N. Saultz, Arpita Gandhi, Laura F. Newell, Brandon Hayes‐Lattin, Richard T. Maziarz, Jessica T. Leonard, Daniel Bottomly, Shannon K. McWeeney, Jennifer Dunlap, Richard D. Press, Gabrielle Meyers, Ronan Swords, Rachel J. Cook, Jeffrey W. Tyner, Brian J. Druker, Elie Traer
Published 2022Artigo -
9
A Phase 1b Study Evaluating the Safety and Efficacy of Venetoclax As Monotherapy or in Combination with Azacitidine for the Treatment of Relapsed/Refractory Myelodysplastic Syndrom... by Amer M. Zeidan, Daniel A. Pollyea, Jacqueline S. Garcia, Andrew M. Brunner, Fernando Roncolato, Uma Borate, Olatoyosi Odenike, Ashish Bajel, Anne Marie Watson, Katharina S. Götze, Florian Nolte, Peter Tan, Wan‐Jen Hong, Martin Dunbar, Ying Zhou, Lori A. Gressick, William B. Ainsworth, Jason G. Harb, Ahmed Hamed Salem, John Hayslip, Ronan Swords, Guillermo Garcia‐Manero
Published 2019Artigo -
10
Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies by Stephen E. Kurtz, Christopher A. Eide, Andy Kaempf, Vishesh Khanna, Samantha L. Savage, Angela Rofelty, Isabel English, Hibery Ho, Ravi Pandya, William J. Bolosky, Hoifung Poon, Michael W. Deininger, Robert H. Collins, Ronan Swords, Justin M. Watts, Daniel A. Pollyea, Bruno C. Medeiros, Elie Traer, Cristina E. Tognon, Motomi Mori, Brian J. Druker, Jeffrey W. Tyner
Published 2017Artigo -
11
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia by Eytan M. Stein, Courtney D. DiNardo, Daniel A. Pollyea, Amir T. Fathi, Gail J. Roboz, Jessica K. Altman, Richard M. Stone, Daniel J. DeAngelo, Ross L. Levine, Ian W. Flinn, Hagop M. Kantarjian, Robert H. Collins, Manish R. Patel, Arthur E. Frankel, Anthony S. Stein, Mikkael A. Sekeres, Ronan Swords, Bruno C. Medeiros, Christophe Willekens, Paresh Vyas, Alessandra Tosolini, Qiang Xu, Robert Knight, Katharine Yen, Sam Agresta, Stéphane de Botton, Martin S. Tallman
Published 2017Artigo -
12
Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial by Naseema Gangat, Christian Marinaccio, Ronan Swords, Justin M. Watts, Sandeep Gurbuxani, Alfred Rademaker, Angela J. Fought, Olga Frankfurt, Jessica K. Altman, Qiang Wen, Noushin Farnoud, Christopher Famulare, Akshar Patel, Roberto Tapia‐Conyer, Rangit Vallapureddy, Stephanie Barath, Amy Graf, Amy Handlogten, Darci Zblewski, Mrinal M. Patnaik, Aref Al‐Kali, Yvonne Dinh, Kristen Englund Prahl, Shradha Patel, Juan Carlos Nobrega, Dalissa Tejera, Amber Thomassen, Juehua Gao, Peng Ji, Raajit K. Rampal, Francis J. Giles, Ayalew Tefferi, Brady L. Stein, John D. Crispino
Published 2019Artigo -
13
Durable Remissions with Ivosidenib in<i>IDH1</i>-Mutated Relapsed or Refractory AML by Courtney D. DiNardo, Eytan M. Stein, Stéphane de Botton, Gail J. Roboz, Jessica K. Altman, Alice S. Mims, Ronan Swords, Robert H. Collins, Gabriel N. Mannis, Daniel A. Pollyea, Will Donnellan, Amir T. Fathi, Arnaud Pigneux, Harry P. Erba, Gabrielle T. Prince, Anthony S. Stein, Geoffrey L. Uy, James M. Foran, Elie Traer, Robert K. Stuart, Martha Arellano, James L. Slack, Mikkael A. Sekeres, Christophe Willekens, Sung Choe, Hongfang Wang, Vickie Zhang, Katharine Yen, Stephanie M. Kapsalis, Hua Yang, David L. Dai, Bin Fan, Meredith A. Goldwasser, Hua Liu, Sam Agresta, Bin Wu, Eyal C. Attar, Martin S. Tallman, Richard M. Stone, Hagop M. Kantarjian
Published 2018Artigo -
14
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia by Robert J. Kreitman, Claire Dearden, Pier Luigi Zinzani, Julio Delgado, Lionel Karlin, Tadeusz Robak, Douglas E. Gladstone, Philipp le Coutre, Sascha Dietrich, Mirjana Gotić, Loree Larratt, Fritz Offner, Gary J. Schiller, Ronan Swords, Larry Bacon, Monica Bocchia, Krimo Bouabdallah, Dimitri Breems, Agostino Cortelezzi, Shira Dinner, Michael Doubek, Bjørn Tore Gjertsen, Marco Gobbi, Andrzej Hellmann, Stéphane Leprêtre, Frédéric Maloisel, Farhad Ravandi, Philippe Rousselot, Mathias Rummel, Tanya Siddiqi, Tamar Tadmor, Xavier Troussard, Cecilia Arana Yi, Giuseppe Saglio, Gail J. Roboz, Kemal Balic, Nathan Standifer, Peng He, Shannon Marshall, Wyndham H. Wilson, Ira Pastan, Nai-Shun Yao, Francis J. Giles
Published 2018Artigo -
15
Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial by Fieke W. Hoff, Ying Huang, Rina Li Welkie, Ronan Swords, Elie Traer, Eytan M. Stein, Tara L. Lin, Prapti A. Patel, Robert H. Collins, Maria R. Baer, Vu H. Duong, William Blum, Martha Arellano, Wendy Stock, Olatoyosi Odenike, Robert L. Redner, Tibor Kovacsovics, Michael W. Deininger, Joshua F. Zeidner, Rebecca L. Olin, Catherine C. Smith, James M. Foran, Gary J. Schiller, Emily Curran, Kristin L Koenig, Nyla A. Heerema, Timothy Chen, Molly Martycz, Mona Stefanos, Sonja Marcus, Leonard Rosenberg, Brian J. Druker, Ross L. Levine, Amy Burd, Ashley O. Yocum, Uma Borate, Alice S. Mims, John C. Byrd, Yazan F. Madanat
Published 2025Carta -
16
Functional genomic landscape of acute myeloid leukaemia by Jeffrey W. Tyner, Cristina E. Tognon, Daniel Bottomly, Beth Wilmot, Stephen E. Kurtz, Samantha L. Savage, Nicola Long, Anna Reister Schultz, Elie Traer, Melissa L. Abel, Anupriya Agarwal, Aurora Blucher, Uma Borate, Jade Bryant, Russell T. Burke, Amy Carlos, Richie Carpenter, Joseph Carroll, Bill H. Chang, Cody Coblentz, Amanda d’Almeida, Rachel J. Cook, Alexey V. Danilov, Kim-Hien T. Dao, Michie Degnin, Deirdre DeVine, James Dibb, David K. Edwards, Christopher A. Eide, Isabel English, Jason Glover, Rachel Henson, Hibery Ho, Abdusebur Jemal, Kara Johnson, Ryan C. Johnson, Brian Junio, Andy Kaempf, Jessica T. Leonard, Chenwei Lin, Selina Qiuying Liu, Pierrette Lo, Marc Loriaux, Samuel B. Luty, Tara A. Macey, Jason D. MacManiman, Jacqueline Martinez, Motomi Mori, Dylan Nelson, Ceilidh Nichols, Jill Peters, Justin Ramsdill, Angela Rofelty, Robert Schuff, Robert P. Searles, Erik Segerdell, Rebecca L. Smith, Stephen E. Spurgeon, Tyler Sweeney, Aashis Thapa, Corinne Visser, Jake Wagner, Kevin Watanabe‐Smith, Kristen Werth, Joelle Wolf, Libbey White, Amy Yates, Haijiao Zhang, Christopher R. Cogle, Robert H. Collins, Denise C. Connolly, Michael W. Deininger, Leylah Drusbosky, Christopher S. Hourigan, Craig T. Jordan, Patricia Kropf, Tara L. Lin, Micaela Martínez, Bruno C. Medeiros, Rachel R. Pallapati, Daniel A. Pollyea, Ronan Swords, Justin M. Watts, Scott J. Weir, David L. Wiest, Ryan M. Winters, Shannon K. McWeeney, Brian J. Druker
Published 2018Artigo -
17
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia by Daniel Bottomly, Nicola Long, Anna Reister Schultz, Stephen E. Kurtz, Cristina E. Tognon, Kara Johnson, Melissa L. Abel, Anupriya Agarwal, Sammantha Avaylon, Erik Benton, Aurora Blucher, Uma Borate, Theodore P. Braun, Jordana Brown, Jade Bryant, Russell T. Burke, Amy Carlos, Bill H. Chang, Hyun Cho, Stephen Christy, Cody Coblentz, Aaron Cohen, Amanda d’Almeida, Rachel J. Cook, Alexey V. Danilov, Kim‐Hien T. Dao, Michie Degnin, James Dibb, Christopher A. Eide, Isabel English, Stuart Hagler, Heath Harrelson, Rachel Henson, Hibery Ho, Sunil K. Joshi, Brian Junio, Andy Kaempf, Yoko Kosaka, Ted Laderas, Matt Lawhead, Hyun-Jung Lee, Jessica T. Leonard, Chenwei Lin, Evan Lind, Selina Qiuying Liu, Pierrette Lo, Marc Loriaux, Samuel B. Luty, Julia E. Maxson, Tara A. Macey, Jacqueline Martinez, Jessica Minnier, Andrea Monteblanco, Motomi Mori, Quinlan Morrow, Dylan Nelson, Justin Ramsdill, Angela Rofelty, Alexandra Rogers, Kyle A. Romine, Peter Ryabinin, Jennifer N. Saultz, David A. Sampson, Samantha L. Savage, Robert Schuff, Robert P. Searles, Rebecca L. Smith, Stephen E. Spurgeon, Tyler Sweeney, Ronan Swords, Aashis Thapa, Karina Thiel-Klare, Elie Traer, Jake Wagner, Beth Wilmot, Joelle Wolf, Guanming Wu, Amy Yates, Haijiao Zhang, Christopher R. Cogle, Robert H. Collins, Michael W. Deininger, Christopher S. Hourigan, Craig T. Jordan, Tara L. Lin, Micaela Martínez, Rachel R. Pallapati, Daniel A. Pollyea, Anthony D. Pomicter, Justin M. Watts, Scott J. Weir, Brian J. Druker, Shannon K. McWeeney, Jeffrey W. Tyner
Published 2022Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Gene
Oncology
Biochemistry
Biology
Myeloid leukemia
Cancer research
Myeloid
Pharmacology
Genetics
Leukemia
Gastroenterology
Adverse effect
Astrobiology
Bone marrow
Chemistry
Gene expression
Immunology
Mutation
Refractory (planetary science)
Cancer
Clinical trial
Computational biology
Disease
Drug
IDH1
Physics
Apoptosis
Azacitidine